Funding · Enterprise Software & IT

Scimplify raises Rs 181 crore Series C round

By Startup Enthusiast · 16 July 2026

What they do

Scimplify helps enterprises develop, manufacture and source specialty chemicals

It raised Rs 180.87 crore ($19.05M) Series C led by Hitachi Ventures

The company's valuation jumped 114% to Rs 2,323 crore ($245M)

Scimplify is raising a Rs 180.87 crore ($19.05M) Series C round.
The round is led by Hitachi Ventures, which is investing Rs 76.15 crore.
Existing investors 3one4 Capital, Accel India, Omnivore Capital, and Bertelsmann Nederland are also participating.
The company's valuation is approximately Rs 2,323 crore ($245M), up 114% from its previous round.
Proceeds will be used for business expansion and general corporate purposes.
This follows a $40M Series B led by Accel in August 2025.

The round marks a significant jump in valuation, reflecting strong growth.
Scimplify's FY25 revenue grew 11X to Rs 200 crore from Rs 17.74 crore in FY24.
The company's loss in FY25 was Rs 25.38 crore.

Scimplify helps enterprises develop, manufacture, and source specialty chemicals.
It serves sectors including pharmaceuticals, agrochemicals, personal care, and other industrial segments.
The company operates through a network of manufacturing partners.
Its platform streamlines the chemical supply chain for clients.

The company plans to use the funds for business expansion and general corporate purposes.

Hitachi Ventures (lead) — Venture capital arm of Hitachi.
3one4 Capital (existing) — Existing investor; post-allotment stake 15.54%.
Accel India (existing) — Existing investor; post-allotment stake 13.84%.
Omnivore Capital (existing) — Existing investor; post-allotment stake 12.14%.
Bertelsmann Nederland (existing) — Existing investor; post-allotment stake 10.26%.

Product: Full-stack manufacturing ecosystem for specialty chemicals combining sourcing, manufacturing, and quality assurance
Customers: Global manufacturers in life sciences, crop sciences, and industrial chemicals seeking sourcing and manufacturing solutions
How it makes money: B2B platform aggregating excess manufacturing capacity across 200+ specialized plants in cost-efficient regions
What sets it apart: Access to network of specialized manufacturers with scientific expertise and regulatory compliance capabilities